SCHEMBL7144535

SCHEMBL7144535

COc1c(C(N)=O)cc(-c2ccc(C)cc2)n2n[c]nc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 3/20 0.40
PIM1 P11309 3/20 0.40
TUBB4A P04350 2/20 0.39
TUBB P07437 2/20 0.39
TUBA3C P0DPH7 2/20 0.39
TUBA1B P68363 2/20 0.39
TUBA4A P68366 2/20 0.39
TUBB4B P68371 2/20 0.39
TUBB3 Q13509 2/20 0.39
TUBB2A Q13885 2/20 0.39
TUBB8 Q3ZCM7 2/20 0.39
TUBA3E Q6PEY2 2/20 0.39
TUBA1A Q71U36 2/20 0.39
TUBA1C Q9BQE3 2/20 0.39
TUBB6 Q9BUF5 2/20 0.39
TUBB2B Q9BVA1 2/20 0.39
TUBB1 Q9H4B7 2/20 0.39
MAPT P10636 2/20 0.35
IKBKB O14920 1/20 0.35
ACVR1 Q04771 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7043074 0.91 NTRK1 (0.45) NTRK1PIM1IKBKBCDC7PARP1
SCHEMBL7146891 0.91 NTRK1 (0.41) NTRK1PIM1TUBB4ATUBBTUBA3C
SCHEMBL7041861 0.89 IKBKB (0.46) NTRK1PIM1MAPTIKBKBCDC7
SCHEMBL7145673 0.88 TLR8 (0.48) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7143148 0.88 NTRK1 (0.34) NTRK1PIM1MAPTIKBKBACVR1
SCHEMBL6875678 0.83 IKBKB (0.35) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7043840 0.83 PARP1 (0.43) MAPTIKBKBCDC7PARP1TP53
SCHEMBL7146568 0.83 IKBKB (0.38) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL6876511 0.82 FYN (0.37) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7143139 0.82 IKBKB (0.41) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed